Board of Management
Dr Bernd Wegener (CEO)
Bernd Wegener has extensive management experience in various areas of responsibility in the pharmaceutical industry and in associations. Following positions at Boehringer Ingelheim KG, Degussa Pharmagruppe, Marion Merrell Dow GmbH and Henning Berlin GmbH, from 1994 to May 2010 he headed the B•R•A•H•M•S Group as founder and CEO. Until 2014 he was Chairman of the Executive Board of the German Pharmaceutical Industry Association (Bundesverband der Pharmazeutischen Industrie, BPI) and has been a board member of the BPI since 2014. He is also a member of the management boards of various companies and of supervisory boards.
Professor Dr Christine Lang
Christine Lang is a professor for microbiology and molecular genetics at Technical University Berlin. In 2001, she founded the biotechnology company Organobalance (Novozymes Berlin GmbH), and 2010 set up Organobalance Medical AG, the precursor to BELANO medical AG. Between 2012 and 2019, she co-chaired the Federal German Government’s bioeconomy council, and since May 2019, she has been president of the Association for General and Applied Microbiology (VAAM). She is responsible for the BELANO medical research and development.
Johannes Lang looks back on extensive management experience in large and medium-sized companies. On the basis of this entrepreneurial experience he has successfully accompanied and built up start-up companies. He is responsible for the operational business.